Ahmed Ba-Ssalamah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ahmed Ba-Ssalamah has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Siegfried Trattnig
High Field MR Center, Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria
3 shared publications - Christian Kienbacher
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
2 shared publications - Michael Trauner
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
2 shared publications - Peter Ferenci
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
2 shared publications A Herneth
1 shared publicationA.M. Herneth
Department of Radiology, University of Vienna, Waehringer Guertel 18–20A-1090 Vienna, Austria
1 shared publication
Latest Publications
- 16 May 2013
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 51 (05) , A66
High-field MR-Spectroscopy (MRS) allows novel insights in alterd hepatic lipid and energy metabolism in NAFLD with potential distinction of NASH and advanced fibrosis
Background/Aims: The rising prevalence of NAFLD and the imperfect gold standard of liver biopsy calls for better diagnostic methods. We aimed to evaluate MRS as non-invasive tool also permitting novel mechanistic and pathogenetic insights into alterations of hepatocellular metabolism in NAFLD. We therefore quantified hepatocellular lipid content (HCL) by 3.0-T 1 H-MRS and 31P-metabolites by 7.0-T 31P-MRS to assess whether MRS permits a non-invasive distinction between NAFL, NASH and different fibrosis stages. Methods: MRS was obtained immediately before liver biopsy in suspected NAFLD and data were correlated with histology. Cut-off levels for steatosis were chosen for biopsy (Kleiner score) and 1 H-MRS signals (3.1, 5.0 and 6.9%). 31P-MRS was applied to determine phosphorus metabolites like phosphomonoester (PME), phosphodiester (PDE), glycerophosphocholine (GPC), NADPH, inorganic phosphate (Pi), α-, β- and γ-ATP levels. Results: 14 patients (5 females, 9 males) were included in this pilot study. Median age was 50 years, BMI 29. Histological diagnosis was simple steatosis (SS; n = 5) and NASH (n = 9; 2 w/cirrhosis). Grades of HCL correlated strongly with the histological grades of steatosis (r = 0.98, p < 0.001). HCL differed between SS and NASH (mean 2.1% vs. 16.2%; p = 0.02) as between SS, NASH and cirrhosis. Changes in cell membrane composition reflected by GPC/(PME+PDE) ratios were lower in NASH than SS (r = 0.60, p = 0.05) and decreased from SS to NASH and cirrhosis (ANOVA; p = 0.05). With higher grades of fibrosis α- ATP/Pi ratios (r = 0.77; p = 0.001) were increasing whereas NADPH/(PME+PDE) ratios seem to decrease (r = 0.5; p = 0.06). Conclusion: High field MRS signals strongly correlate with histological grades of steatosis. In vivo 7.0-T 31P-MRS shows promising results for distinction between histologically verified SS and NASH as between different degrees of fibrosis indicating alterations in the cell membrane configuration and hepatic energy metabolism. Non-invasive monitoring of NAFLD patients appears feasible but further validation is required.
- 16 May 2013
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 51 (05) , A66
High-field MR-Spectroscopy (MRS) allows novel insights in alterd hepatic lipid and energy metabolism in NAFLD with potential distinction of NASH and advanced fibrosis
Background/Aims: The rising prevalence of NAFLD and the imperfect gold standard of liver biopsy calls for better diagnostic methods. We aimed to evaluate MRS as non-invasive tool also permitting novel mechanistic and pathogenetic insights into alterations of hepatocellular metabolism in NAFLD. We therefore quantified hepatocellular lipid content (HCL) by 3.0-T 1 H-MRS and 31P-metabolites by 7.0-T 31P-MRS to assess whether MRS permits a non-invasive distinction between NAFL, NASH and different fibrosis stages. Methods: MRS was obtained immediately before liver biopsy in suspected NAFLD and data were correlated with histology. Cut-off levels for steatosis were chosen for biopsy (Kleiner score) and 1 H-MRS signals (3.1, 5.0 and 6.9%). 31P-MRS was applied to determine phosphorus metabolites like phosphomonoester (PME), phosphodiester (PDE), glycerophosphocholine (GPC), NADPH, inorganic phosphate (Pi), α-, β- and γ-ATP levels. Results: 14 patients (5 females, 9 males) were included in this pilot study. Median age was 50 years, BMI 29. Histological diagnosis was simple steatosis (SS; n = 5) and NASH (n = 9; 2 w/cirrhosis). Grades of HCL correlated strongly with the histological grades of steatosis (r = 0.98, p < 0.001). HCL differed between SS and NASH (mean 2.1% vs. 16.2%; p = 0.02) as between SS, NASH and cirrhosis. Changes in cell membrane composition reflected by GPC/(PME+PDE) ratios were lower in NASH than SS (r = 0.60, p = 0.05) and decreased from SS to NASH and cirrhosis (ANOVA; p = 0.05). With higher grades of fibrosis α- ATP/Pi ratios (r = 0.77; p = 0.001) were increasing whereas NADPH/(PME+PDE) ratios seem to decrease (r = 0.5; p = 0.06). Conclusion: High field MRS signals strongly correlate with histological grades of steatosis. In vivo 7.0-T 31P-MRS shows promising results for distinction between histologically verified SS and NASH as between different degrees of fibrosis indicating alterations in the cell membrane configuration and hepatic energy metabolism. Non-invasive monitoring of NAFLD patients appears feasible but further validation is required.
- 26 April 2013
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 185 (S 01) , WI_PO13
Gd-EOB-verstärkte vs. diffusionsgewichtete Ga-68-DOTANOC PET/MRT zur Erfassung neuroendokriner Tumore des oberen Abdomens
Ziele: Ziel war es, co-registrierte und fusionierte Gd-EOB-verstärkte Ga-68-DOTANOC PET/MRT Bilddaten mit Ga-68-DOTANOC PET/DWI (diffusionsgewichtete MRT) Bilddaten hinsichtlich der Erfassung neuroendokriner Tumore (NETs) des oberen Abdomens zu vergleichen. Methode: 18 Patienten mit histologisch verifizierten oder klinisch suspizierten abdominellen NETs wurden in die retrospektive Studie eingeschlossen. Bei allen Patienten wurde eine Ga-68-DOTANOC PET/CT sowie eine MRT des Abdomens (mit dynamischen Gd-EOB-verstärkten T1-gewichteten Sequenzen und atemgetriggerten DWI-Sequenzen [b-50, b-300 und b-600]) zur Primumsuche, zum Staging oder zum Restaging durchgeführt. Die co-registrierten und farbfusionierten Gd-EOB-verstärkten PET/MRT und PET/DWI Daten wurden separat von einem Nuklearmediziner und einem Radiologen im Konsens ausgewertet. Sensitivität und Spezifität für die NET-Detektion wurden auf Regions-, Organ- sowie Patientenbasis ausgewertet. Ergebnis: 87 von 684 analysierten anatomischen Regionen in 23 von 270 Organen wurden in 14 von 18 in die Studie eingeschlossenen Patienten als NET-positiv gewertet. Regions-basierte Sensitivitäten und Spezifitäten waren 97,7% und 99,7% für die Gd-EOB-verstärkte PET/MRI, und 98,9% und 99,7% für die PET/DWI. Organ-basierte Sensitivitäten und Spezifitäten waren 91,3% und 99,6% für die Gd-EOB-verstärkte PET/MRI, und 95,7% und 99,6% für die PET/DWI. Patienten-basierte Sensitivitäten und Spezifitäten waren 100% und 100% für die Gd-EOB-verstärkte PET/MRI, und 100% und 75% für die PET/DWI. Es fand sich kein signifikanter Unterschied hinsichtlich der Sensitivität und Spezifität der beiden Methoden. Schlussfolgerung: Die Gd-EOB-verstärkte Ga-68-DOTANOC PET/MRT und die Ga-68-DOTANOC PET/DWI sind in gleichem Maße für die Detektion von NETs des oberen Abdomens geeignet. Korrespondierender Autor: Mayerhoefer ME Medizinische Universität Wien, Univ.-Klinik für Radiodiagnostik, PET/CT Zentrum, Abteilung für Allgemeine und Kinderradiologie, Waehringer Guertel 18 – 20, 1090, Wien E-Mail: [email protected]
- 26 April 2013
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 185 (S 01) , WI_PO13
Gd-EOB-verstärkte vs. diffusionsgewichtete Ga-68-DOTANOC PET/MRT zur Erfassung neuroendokriner Tumore des oberen Abdomens
Ziele: Ziel war es, co-registrierte und fusionierte Gd-EOB-verstärkte Ga-68-DOTANOC PET/MRT Bilddaten mit Ga-68-DOTANOC PET/DWI (diffusionsgewichtete MRT) Bilddaten hinsichtlich der Erfassung neuroendokriner Tumore (NETs) des oberen Abdomens zu vergleichen. Methode: 18 Patienten mit histologisch verifizierten oder klinisch suspizierten abdominellen NETs wurden in die retrospektive Studie eingeschlossen. Bei allen Patienten wurde eine Ga-68-DOTANOC PET/CT sowie eine MRT des Abdomens (mit dynamischen Gd-EOB-verstärkten T1-gewichteten Sequenzen und atemgetriggerten DWI-Sequenzen [b-50, b-300 und b-600]) zur Primumsuche, zum Staging oder zum Restaging durchgeführt. Die co-registrierten und farbfusionierten Gd-EOB-verstärkten PET/MRT und PET/DWI Daten wurden separat von einem Nuklearmediziner und einem Radiologen im Konsens ausgewertet. Sensitivität und Spezifität für die NET-Detektion wurden auf Regions-, Organ- sowie Patientenbasis ausgewertet. Ergebnis: 87 von 684 analysierten anatomischen Regionen in 23 von 270 Organen wurden in 14 von 18 in die Studie eingeschlossenen Patienten als NET-positiv gewertet. Regions-basierte Sensitivitäten und Spezifitäten waren 97,7% und 99,7% für die Gd-EOB-verstärkte PET/MRI, und 98,9% und 99,7% für die PET/DWI. Organ-basierte Sensitivitäten und Spezifitäten waren 91,3% und 99,6% für die Gd-EOB-verstärkte PET/MRI, und 95,7% und 99,6% für die PET/DWI. Patienten-basierte Sensitivitäten und Spezifitäten waren 100% und 100% für die Gd-EOB-verstärkte PET/MRI, und 100% und 75% für die PET/DWI. Es fand sich kein signifikanter Unterschied hinsichtlich der Sensitivität und Spezifität der beiden Methoden. Schlussfolgerung: Die Gd-EOB-verstärkte Ga-68-DOTANOC PET/MRT und die Ga-68-DOTANOC PET/DWI sind in gleichem Maße für die Detektion von NETs des oberen Abdomens geeignet. Korrespondierender Autor: Mayerhoefer ME Medizinische Universität Wien, Univ.-Klinik für Radiodiagnostik, PET/CT Zentrum, Abteilung für Allgemeine und Kinderradiologie, Waehringer Guertel 18 – 20, 1090, Wien E-Mail: [email protected]
- 30 September 2004
- Published by Elsevier in European Journal of Radiology
- Vol. 51 (3) , 292
Imaging of the Pancreas: Cystic and Rare Tumors, C. Procacci, A.J. Megibow, Springer-Verlag, Berlin, 2003, pp. 302, Euro 139.95, ISBN 3-540-42742-2
- 30 September 2004
- Published by Elsevier in European Journal of Radiology
- Vol. 51 (3) , 292
Imaging of the Pancreas: Cystic and Rare Tumors, C. Procacci, A.J. Megibow, Springer-Verlag, Berlin, 2003, pp. 302, Euro 139.95, ISBN 3-540-42742-2
- 1 July 2003
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 38 (7) , 415-422
Effect of Contrast Dose and Field Strength in the Magnetic Resonance Detection of Brain Metastases
To compare the diagnostic efficacy of a standard and cumulative triple dose of magnetic resonance (MR) imaging contrast agent in the evaluation of brain metastases using a high-field 3.0 T MR unit versus a standard field 1.5 T MR unit. Twenty-two patients with suspected brain metastases were examined at both field strengths using identical postcontrast coronal 3D gradient echo with magnetization preparation, which was adjusted separately for each field strength. In both groups initially, iv injection of 0.1 mmol/kg body weight gadolinium chelate (gadodiamide) and thereafter, 0.2 mmol/kg body weight gadodiamide were administered. Subjective assessment of the images was performed independently by 3 neuroradiologists. Objective measurement of signal-to-noise and contrast-to-noise ratios was obtained. The subjective assessment of cumulative triple-dose 3.0 T images obtained the best results compared with other sequences, detecting 84 metastases, followed by 1.5 T cumulative triple-dose enhanced images with 81 brain metastases. The objective assessment confirmed those results, showing significantly higher signal-to-noise and contrast-to-noise ratios with 3.0 T than with 1.5 T. Cumulative triple-dose images of both field strengths were superior to standard field strengths. However, administration of gadodiamide contrast agent produces higher contrast between tumor and normal brain on 3.0 T than on 1.5 T, resulting in better detection of brain metastases and leptomeningeal involvement.
- 1 July 2003
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 38 (7) , 415-422
Effect of Contrast Dose and Field Strength in the Magnetic Resonance Detection of Brain Metastases
To compare the diagnostic efficacy of a standard and cumulative triple dose of magnetic resonance (MR) imaging contrast agent in the evaluation of brain metastases using a high-field 3.0 T MR unit versus a standard field 1.5 T MR unit. Twenty-two patients with suspected brain metastases were examined at both field strengths using identical postcontrast coronal 3D gradient echo with magnetization preparation, which was adjusted separately for each field strength. In both groups initially, iv injection of 0.1 mmol/kg body weight gadolinium chelate (gadodiamide) and thereafter, 0.2 mmol/kg body weight gadodiamide were administered. Subjective assessment of the images was performed independently by 3 neuroradiologists. Objective measurement of signal-to-noise and contrast-to-noise ratios was obtained. The subjective assessment of cumulative triple-dose 3.0 T images obtained the best results compared with other sequences, detecting 84 metastases, followed by 1.5 T cumulative triple-dose enhanced images with 81 brain metastases. The objective assessment confirmed those results, showing significantly higher signal-to-noise and contrast-to-noise ratios with 3.0 T than with 1.5 T. Cumulative triple-dose images of both field strengths were superior to standard field strengths. However, administration of gadodiamide contrast agent produces higher contrast between tumor and normal brain on 3.0 T than on 1.5 T, resulting in better detection of brain metastases and leptomeningeal involvement.
- 1 May 2003
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 23 (3) , 625-644
Dedicated Multidetector CT of the Stomach: Spectrum of Diseases
Multidetector computed tomography (CT) offers new opportunities in imaging of the gastrointestinal tract. When thin collimation is used, near-isotropic imaging of the stomach is possible, allowing high-quality multiplanar reformation and three-dimensional reconstruction of gastric images. Proper distention of the stomach and optimally timed administration of intravenous contrast material are required to detect and characterize disease. In contrast to gastroscopy and double-contrast studies of the stomach, CT provides information about both the gastric wall and the extragastric extent of disease. Preoperative staging of gastric carcinoma appears to be the main clinical indication for multidetector CT. In addition, multidetector CT allows detection of other gastric malignancies (lymphoma, carcinoid tumors, metastases, gastrointestinal stromal tumors) and benign gastric tumors (neural tumors, polyps). Gastric inflammation (gastritis, ulcers, Ménétrier disease) and miscellaneous gastric conditions (emphysema, gastric outlet obstruction, varices) can also be visualized with multidetector CT. Multidetector CT is a valuable tool for the evaluation of gastric wall disease and serves as an adjunct to endoscopy.
- 1 May 2003
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 23 (3) , 625-644
Dedicated Multidetector CT of the Stomach: Spectrum of Diseases
Multidetector computed tomography (CT) offers new opportunities in imaging of the gastrointestinal tract. When thin collimation is used, near-isotropic imaging of the stomach is possible, allowing high-quality multiplanar reformation and three-dimensional reconstruction of gastric images. Proper distention of the stomach and optimally timed administration of intravenous contrast material are required to detect and characterize disease. In contrast to gastroscopy and double-contrast studies of the stomach, CT provides information about both the gastric wall and the extragastric extent of disease. Preoperative staging of gastric carcinoma appears to be the main clinical indication for multidetector CT. In addition, multidetector CT allows detection of other gastric malignancies (lymphoma, carcinoid tumors, metastases, gastrointestinal stromal tumors) and benign gastric tumors (neural tumors, polyps). Gastric inflammation (gastritis, ulcers, Ménétrier disease) and miscellaneous gastric conditions (emphysema, gastric outlet obstruction, varices) can also be visualized with multidetector CT. Multidetector CT is a valuable tool for the evaluation of gastric wall disease and serves as an adjunct to endoscopy.
- 1 July 2000
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 18 (6) , 635-640
Preoperative fast MRI of brain tumors using three-dimensional segmented echo planar imaging compared to three-dimensional gradient echo technique
- 1 July 2000
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 18 (6) , 635-640
Preoperative fast MRI of brain tumors using three-dimensional segmented echo planar imaging compared to three-dimensional gradient echo technique
- 1 April 2000
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 18 (3) , 237-243
Ultrafast magnetic resonance imaging of the brain
- 1 April 2000
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 18 (3) , 237-243
Ultrafast magnetic resonance imaging of the brain